Evidence map›Paper›PMID 40697947›Full record

ArticleThe journal of allergy and clinical immunology. Global2025

Hyper-IgE syndrome: A rare case report.

Lee Smith, Ahmed Rafei, Susanna Caminada, Salma Barakat, Sami Medani Abd Elwahab, Damiano Pizzol, Abdelmounem Eltayeb Abdo

Abstract readCase Reports
In one paragraph

Article in The journal of allergy and clinical immunology. Global, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lee SmithCentre for Health, Performance and Wellbeing, Anglia Ruskin University, Cambridge, United Kingdom.
Ahmed RafeiNational Centre of Gastrointestinal and Liver Disease, Ibn Sina Hospital, Khartoum, Sudan.
Susanna CaminadaHealth Unit Eni, Rome, Italy.
Salma BarakatNational Centre of Gastrointestinal and Liver Disease, Ibn Sina Hospital, Khartoum, Sudan.
Sami Medani Abd ElwahabNational Centre of Gastrointestinal and Liver Disease, Ibn Sina Hospital, Khartoum, Sudan.
Damiano PizzolHealth Unit Eni, Maputo, Mozambique.
Abdelmounem Eltayeb AbdoNational Centre of Gastrointestinal and Liver Disease, Ibn Sina Hospital, Khartoum, Sudan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyper-IgE syndrome (HIES) is a rare and sporadic primary immunodeficiency usually characterized by atopic dermatitis, recurrent skin staphylococcal infections, recurrent pulmonary infections, and elevated IgE levels. Due to the rarity of the syndrome and its nonspecific and wide presentation, the diagnosis is difficult and arises with other diagnoses including other types of primitive chronic granulomatous disease or acquired immunodeficiency, severe atopic dermatitis, or cystic fibrosis or chronic respiratory infection as tuberculosis. To date, there is no gold standard management and treatments aim to relieve symptoms and avoid complications. We report on a 30-year-old female with a long-time misdiagnosed HIES.

Indexed as

HIESHyper-IgE syndromeIgEJob syndrome

Identifiers

PMID40697947
PMCPMC12281938

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.